Completed PHASE1 INTERVENTIONAL 1-arm NCT00108173

Brain Reaction to Treatment of Nicotine Dependence

Neural Substrates of Treatment for Nicotine Dependence

Sponsor: US Department of Veterans Affairs

Interventions Zyban

Updated 6 times since 2017 Last updated: Apr 5, 2013 Started: Oct 31, 2002 Primary completion: Apr 30, 2007 Completion: Jun 30, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00108173, this PHASE1 trial focuses on Nicotine Dependence and remains completed. Sponsored by US Department of Veterans Affairs, it has been updated 6 times since 2002, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Aug 2018 — Jan 2021 [monthly]

Completed PHASE1
Jun 2018 — Aug 2018 [monthly]

Completed PHASE1

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Oct 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

US Department of Veterans Affairs

Data source: VA Office of Research and Development

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• West Los Angeles, United States